Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifs.

The Journal of Biological Chemistry
Pascal Kienlen-CampardJean-Noël Octave

Abstract

The beta-amyloid peptide (Abeta) is the major constituent of the amyloid core of senile plaques found in the brain of patients with Alzheimer disease. Abeta is produced by the sequential cleavage of the amyloid precursor protein (APP) by beta- and gamma-secretases. Cleavage of APP by gamma-secretase also generates the APP intracellular C-terminal domain (AICD) peptide, which might be involved in regulation of gene transcription. APP contains three Gly-XXX-Gly (GXXXG) motifs in its juxtamembrane and transmembrane (TM) regions. Such motifs are known to promote dimerization via close apposition of TM sequences. We demonstrate that pairwise replacement of glycines by leucines or isoleucines, but not alanines, in a GXXXG motif led to a drastic reduction of Abeta40 and Abeta42 secretion. beta-Cleavage of mutant APP was not inhibited, and reduction of Abeta secretion resulted from inhibition of gamma-cleavage. It was anticipated that decreased gamma-cleavage of mutant APP would result from inhibition of its dimerization. Surprisingly, mutations of the GXXXG motif actually enhanced dimerization of the APP C-terminal fragments, possibly via a different TM alpha-helical interface. Increased dimerization of the TM APP C-terminal domain di...Continue Reading

References

Mar 1, 1994·Nature Structural Biology·M A LemmonD M Engelman
Sep 11, 1999·Trends in Neurosciences·W Annaert, B De Strooper
Nov 24, 1999·Molecular and Cellular Neurosciences·I HussainG Christie
Mar 15, 2000·Journal of Molecular Biology·W P Russ, D M Engelman
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·X LinJ Tang
Jan 26, 2002·The Journal of Biological Chemistry·Dieter EdbauerChristian Haass
Feb 28, 2002·The Journal of Biological Chemistry·Pascal Kienlen-CampardJean-Noël Octave
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Malcolm A LeissringFrank M LaFerla
Apr 20, 2002·Biophysical Journal·Markus EilersSteven O Smith
Jun 14, 2002·Neuron·Julius O Ebinu, Bruce A Yankner
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·Mark E Fortini
Nov 25, 2003·The Journal of Biological Chemistry·Sheu-Fen LeeGang Yu
Mar 27, 2004·The Journal of Biological Chemistry·Xinwei Cao, Thomas C Südhof
Apr 17, 2004·The Journal of Biological Chemistry·Didier Pitsi, Jean-Noël Octave
Aug 18, 2004·Current Opinion in Structural Biology·Alessandro SenesWilliam F DeGrado
Jun 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Vincent T Marchesi
Sep 30, 2005·The EMBO Journal·Peter SobaKonrad Beyreuther

❮ Previous
Next ❯

Citations

Nov 23, 2011·Cellular and Molecular Life Sciences : CMLS·Simone IsbertClaus U Pietrzik
Nov 17, 2011·Journal of the American Chemical Society·Tiandi ZhuangCharles R Sanders
Mar 12, 2009·Journal of the American Chemical Society·Naoyuki MiyashitaYuji Sugita
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Takeshi SatoSteven O Smith
Jul 15, 2009·The Journal of Biological Chemistry·Simone EggertEdward H Koo
Mar 30, 2010·The Journal of Biological Chemistry·Richard M PageHarald Steiner
Oct 30, 2012·The Journal of Biological Chemistry·Alex M SykesElizabeth J Coulson
Apr 2, 2009·The Journal of Biological Chemistry·Matthias GralleFred S Wouters
Apr 30, 2011·Molecular Neurodegeneration·Hui Zheng, Edward H Koo
Aug 3, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Roger LefortMichael Shelanski
Apr 5, 2013·EMBO Molecular Medicine·Nathalie PierrotJean-Noël Octave
Jan 12, 2011·Annual Review of Physical Chemistry·John E Straub, D Thirumalai
May 1, 2009·Expert Review of Neurotherapeutics·Taisuke Tomita
May 16, 2012·FEBS Letters·Kirill D NadezhdinAlexander S Arseniev
Jun 14, 2014·Journal of the American Chemical Society·Laura DominguezD Thirumalai
Aug 3, 2010·Journal of Ethnopharmacology·Salim HageJoëlle Quetin-Leclercq
Apr 29, 2009·The Journal of Comparative Neurology·Howard J Federoff
Nov 30, 2011·Journal of Neurochemistry·Blaine R RobertsJames A Duce
Dec 14, 2011·Journal of Neurochemistry·Stéphanie Chasseigneaux, Bernadette Allinquant
Jun 28, 2011·Journal of Neurochemistry·Megumi Asada-UtsugiAyae Kinoshita
Aug 6, 2015·Biochemistry·Mark G Teese, Dieter Langosch
Mar 21, 2015·Biochimica Et Biophysica Acta·Michael Stangl, Dirk Schneider
Apr 20, 2010·Cell Adhesion & Migration·Naouel Ben KhalifaPascal Kienlen-Campard
Feb 3, 2015·Journal of Ethnopharmacology·Salim HagePascal Kienlen-Campard

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.